BARICADE.pyelonephritis
banner
baricadep.bsky.social
BARICADE.pyelonephritis
@baricadep.bsky.social
DFG funded interdisciplinary research group. Investigates bacterial virulence factors, intrarenal innate immune defense, host-pathogen interactions and environmental modulating factors, pharmacological aspects of antiinfective treatment in pyelonephritis.
Check out this idw press release about our SP7 group’s findings on how the kidney protects itself from bacteria during glucosuria.
Wie schützt sich die Niere bei Glukosurie vor Bakterien?
Bakterien nutzen Zucker als Nährstoff und wachsen darin. Urin ist praktisch zuckerfrei. Eine Behandlung mit SGLT2-Hemmern, die bei Diabetes 2 sowie Herz- oder Nierenerkrankungen eingeset...
weiterlesen
February 14, 2026 at 5:53 PM
Proud to share new data from our SP7 group: Sodium glucose transporter 2 inhibition maintains kidney antibacterial response by decreasing complement C1q. Feedback welcome.
www.kidney-international.org/article/S008...
February 5, 2026 at 9:45 PM
Poster award for ‘Uncovering the complexities of pyelonephritis: a multi-model system investigation’ to Annika Hilger @ukm.de - congratulations!
February 4, 2026 at 7:04 PM
December 2025 - great BARICADE retreat in Bonn, highly successful presentation of individual projects.
baricade.de/events/
February 3, 2026 at 5:43 PM